Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-20

FDA Approved: ACITRETIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ACITRETIN (acitretin) from Teva Pharmaceuticals USA, Inc. under ANDA 202897.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)

Snippet

SUPPL AP for ACITRETIN (ACITRETIN)